Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics
The Pharmacogenomics Journal2012Vol. 13(5), pp. 456–463
Citations Over TimeTop 10% of 2012 papers
Yuan Ji, J M Biernacka, Scott J. Hebbring, Yubo Chai, G. Douglas Jenkins, A Batzler, Karen Snyder, Maureen S. Drews, Zeruesenay Desta, David A. Flockhart, Taisei Mushiroda, Michiaki Kubo, Yoshimasa Nakamura, Naoyuki Kamatani, Daniel J. Schaid, Richard M. Weinshilboum, David A. Mrazek
Related Papers
- → <p>Pharmacogenomics In Pharmacy Practice: Current Perspectives</p>(2019)28 cited
- → Metformin Pharmacogenomics: Biomarkers to Mechanisms(2014)17 cited
- → Introduction to Pharmacogenomics: Promises, Opportunities, and Limitations(2002)11 cited
- Pharmacogenomics and Rational Use of Drugs(2001)
- Pharmacogenomics and Individualized Medication(2001)